The team of Professor Fang Wentao of the Affiliated Chest Hospital released the world's first postoperative recurrence prediction model for thymic tumors

Recently, the China Thymic Oncology Collaborative Group (ChART) research team led by Professor Fang Wentao, director of the Thoracic Surgery Department of the Affiliated Chest Hospital, published in the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (ISLAC) and an international authoritative academic journal in the field of thoracic oncology.

The Affiliated Chest Hospital has accumulated rich experience and achievements in the clinical diagnosis, treatment and research of mediastinal diseases, especially thymic tumors

This study established the world's first postoperative recurrence prediction model for thymic tumors, and provided corresponding long-term follow-up recommendations for patients with different recurrence risks, which not only helps in timely detection and treatment, but also reduces unnecessary examinations, enabling patients to Get a safer and better postoperative quality of life